Insud Pharma
Javier Latorre Guerra serves as the Services and Indirect Purchases Category Manager at Insud Pharma since May 2023, previously holding positions at Carrefour España as Purchasing Manager for Investments Maintenance & Operation Services and Area Manager for various operational services. Prior experience includes serving as Global Category Manager for Indirect Materials & Services at Grupo Telepizza from November 2014 to September 2021, overseeing substantial purchasing budgets and supplier management. Additionally, Javier Latorre Guerra worked at Berlys Corporación where responsibilities included managing purchases for services and machinery and controlling budgetary reports. Early career experience includes positions at DHL focused on general services and procurement. Javier Latorre Guerra holds a degree in Business Administration from Universidad de Alcalá and an MBA in Logistics and Purchases, among other relevant qualifications.
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.